U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis - Argus Press Get link Facebook Twitter Pinterest Email Other Apps September 28, 2020 U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis Argus Press Get link Facebook Twitter Pinterest Email Other Apps Comments
Understanding Pulmonary Fibrosis - Hour Detroit Magazine September 26, 2019 Understanding Pulmonary Fibrosis Hour Detroit Magazine Read more
US revokes emergency use of malaria drugs versus coronavirus - KSTP June 15, 2020 US revokes emergency use of malaria drugs versus coronavirus KSTP Read more
What’s next for rheumatoid arthritis and cannabis? - The GrowthOp September 23, 2019 What’s next for rheumatoid arthritis and cannabis? The GrowthOp One-and-a-half million people in the United States suffer from rheumatoid arthritis (RA). In fact, The Arthritis Foundation estimates that three times as many ... Read more
Comments
Post a Comment